InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Campbell Bradley L, Chief Operating Officer. Director active across 2 companies, notably Amicus Therapeutics, INC.. Cumulatively, 76 filings have been recorded. Split: 0 buy · 9 sells. Total volume traded: €944k. History available since 3 May 2021. The latest transaction was disclosed on 27 April 2026 (Disposition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Campbell Bradley L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations76 total
1,008,680 shares@ US$14.500.31% mcap68.5% of flowCommon StockSEC:0001193125-26-182241:0
22,500 shares@ US$14.34841.4% of flowCommon StockSEC:0001193125-26-092114:0
75,000 shares@ US$6.102.0% of flowCommon StockSEC:0001193125-26-019838:0
108,602 shares@ US$14.2522.9% of flowCommon StockSEC:0001193125-25-337338:0
70,426 shares@ US$9.032.9% of flowCommon StockSEC:0001193125-25-323151:0
14,587 shares@ US$9.030.6% of flowCommon StockSEC:0001193125-25-307200:0
14,587 shares@ US$9.030.6% of flowCommon StockSEC:0001193125-25-301018:0
13,375 shares@ US$8.901.9% of flowCommon StockSEC:0000950170-25-041503:0
400 shares@ US$9.030.1% of flowCommon StockSEC:0000950170-25-025118:0
137,075 shares0Common StockSEC:0000950170-25-020034:0
20,647 shares@ US$9.313.2% of flowCommon StockSEC:0000950170-25-002425:0
7,500 shares@ US$8.611.1% of flowCommon StockSEC:0000950170-24-132964:0
7,500 shares@ US$10.01661.2% of flowCommon StockSEC:0000950170-24-132964:1
7,901 shares@ US$12.281.5% of flowCommon StockSEC:0000950170-24-123557:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-120981:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-112905:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-104073:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-091099:0
6,100 shares@ US$10.00481.0% of flowCommon StockSEC:0000950170-24-082476:1
6,100 shares@ US$8.610.8% of flowCommon StockSEC:0000950170-24-082476:0
1,400 shares@ US$8.610.2% of flowCommon StockSEC:0000950170-24-081542:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-069357:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-053058:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-041367:0
13,375 shares@ US$11.482.5% of flowCommon StockSEC:0000950170-24-033713:0
25 of 76 declarations
About Campbell Bradley L
Campbell Bradley L is Directeur des Opérations and has reported 76 filings in total. Across the 76 sampled recent filings, all relate to Amicus Therapeutics, INC., with EUR 0 of buys and EUR 13419788 of sells, mainly over the period from 2016-01-06 to 2026-04-27. The most frequent transaction nature is Levée d'options.
